PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how fast children, who have had a recent kidney
transplant, absorb, breakdown and eliminate mycophenolic acid (CellCept) following their
prescribed dose. The results may lead to better dosing based on individual needs.